# Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial

> **NCT02145767** · PHASE2 · COMPLETED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 850 (estimated)

## Conditions studied

- Miscarriage
- Preterm Birth

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02145767
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2021-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145767, "Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02145767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*